Exelixis Inc. (NASDAQ:EXEL) went up by 4.43% from its latest closing price compared to the recent 1-year high of $27.80. The company’s stock price has collected 18.02% of gains in the last five trading sessions. Press Release reported on 01/10/21 that Exelixis Announces Preliminary Fourth Quarter and Full Year 2020 Financial Results, Provides 2021 Financial Guidance, and Outlines Key Priorities and Anticipated Milestones For 2021
Is It Worth Investing in Exelixis Inc. (NASDAQ :EXEL) Right Now?
Exelixis Inc. (NASDAQ:EXEL) scored a price-to-earnings ratio above its average ratio, recording 52.65 x from its present earnings ratio. Plus, the 36-month beta value for EXEL is at 1.12. Opinions of the stock are interesting as 10 analysts out of 13 who provided ratings for Exelixis Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 3 rated it as “hold,” and 0 as “sell.”
The average price from analysts is $30.83, which is $5.78 above the current price. EXEL currently public float of 302.86M and currently shorts hold a 4.75% ratio of that float. Today, the average trading volume of EXEL was 2.22M shares.
EXEL’s Market Performance
EXEL stocks went up by 18.02% for the week, with a monthly jump of 30.34% and a quarterly performance of 5.17%, while its annual performance rate touched 36.55%. The volatility ratio for the week stands at 4.45% while the volatility levels for the past 30 days are set at 3.54% for Exelixis Inc.. The simple moving average for the period of the last 20 days is 20.96% for EXEL stocks with a simple moving average of 12.61% for the last 200 days.
Analysts’ Opinion of EXEL
Many brokerage firms have already submitted their reports for EXEL stocks, with Barclays repeating the rating for EXEL by listing it as a “Overweight.” The predicted price for EXEL in the upcoming period, according to Barclays is $26 based on the research report published on March 04th of the previous year 2020.
SunTrust, on the other hand, stated in their research note that they expect to see EXEL reach a price target of $31. The rating they have provided for EXEL stocks is “Buy” according to the report published on January 13th, 2020.
BofA/Merrill gave a rating of “Buy” to EXEL, setting the target price at $22 in the report published on November 13th of the previous year.
EXEL Trading at 24.67% from the 50-Day Moving Average
After a stumble in the market that brought EXEL to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -9.28% of loss for the given period.
Volatility was left at 3.54%, however, over the last 30 days, the volatility rate increased by 4.45%, as shares surge +26.93% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +20.55% upper at present.
During the last 5 trading sessions, EXEL rose by +18.02%, which changed the moving average for the period of 200-days by +46.37% in comparison to the 20-day moving average, which settled at $21.12. In addition, Exelixis Inc. saw 25.66% in overturn over a single year, with a tendency to cut further gains.
Reports are indicating that there were more than several insider trading activities at EXEL starting from Lamb Peter, who sale 65,000 shares at the price of $20.32 back on Jan 04. After this action, Lamb Peter now owns 283,124 shares of Exelixis Inc., valued at $1,320,800 using the latest closing price.
Lamb Peter, the EVP, Scientific Strategy & CSO of Exelixis Inc., sale 65,000 shares at $20.01 during a trade that took place back on Dec 18, which means that Lamb Peter is holding 283,124 shares at $1,300,650 based on the most recent closing price.
Stock Fundamentals for EXEL
Current profitability levels for the company are sitting at:
- +38.18 for the present operating margin
- +96.58 for the gross margin
The net margin for Exelixis Inc. stands at +33.17. The total capital return value is set at 24.31, while invested capital returns managed to touch 21.16. Equity return is now at value 8.50, with 7.60 for asset returns.
Based on Exelixis Inc. (EXEL), the company’s capital structure generated 3.01 points at debt to equity in total, while total debt to capital is 2.92. Total debt to assets is 2.68, with long-term debt to equity ratio resting at 2.85. Finally, the long-term debt to capital ratio is 2.76.
When we switch over and look at the enterprise to sales, we see a ratio of 4.71, with the company’s debt to enterprise value settled at 0.01. The receivables turnover for the company is 6.47 and the total asset turnover is 0.58. The liquidity ratio also appears to be rather interesting for investors as it stands at 7.08.